Home / Events /

Almac Diagnostic Services is delighted to be attending World CB & CDx USA taking place in Boston, MA from 4th-6th September

About World CB & CDx USA

Across 2 days, 80+ world-class industry stakeholders will address the most critical challenges in Biomarker Discovery & Translational DevelopmentClinical Biomarker Development, and CDx Development & Commercialization, to provide you with unparalleled insights to:

  • Recognizing biomarkers & CDx development advancements in multiple disease areas spanning oncology and non-oncology indications including NASH, Alzheimer’s & Parkinson’s to revolutionize personalized medicine efforts
  • Exploring the regulatory, commercialization, and market access landscapes to take actional measures for the wider adoption and commercialization of testing and enable equitable access for patients
  • Overcoming the challenges of analytically validating clinical biomarkers to ensure clinical trial robustness
  • Utilize bioinformatics and AI for biomarker discovery, patient stratification, and clinical biomarker validation to enhance underlying biology and pathology understanding for biomarkers
  • Collaborate with the hottest CDx developers to supercharge the co-development of therapeutics and companion diagnostics

For more information, click here.

Share this event

Share on Facebook Share on Twitter Share on LinkedIn
Kevin Ellison

Kevin Ellison

Head of Business Development, North America


Head of Business Development, North America | Almac Diagnostic Services

Tom Fedolak

Tom Fedolak

NC Business Development Manager


NC Business Development Manager | Almac Diagnostic Services

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies